Compare Aurora Cannabis Inc (ACB) vs The Coca-Cola Co K (KO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aurora Cannabis Inc vs The Coca-Cola Co K — how do they compare? Aurora Cannabis Inc trades at $3.45 (market cap $178.92M), while The Coca-Cola Co K trades at $86.57 (market cap $373.76B). The key difference: The Coca-Cola Co K is far larger — about 2089× Aurora Cannabis Inc's market cap, and The Coca-Cola Co K pays a 2.44% dividend while Aurora Cannabis Inc pays none. Which is the better fit depends on your goals.
| ACB | KO | |
|---|---|---|
Market Cap | $178.92M | $373.76B |
Sector | Health | Consumer Staples |
52-Week High | $6.23 | $89.08 |
52-Week Low | $2.58 | $65.67 |
Enterprise Value | $123.48M | $400.93B |
Volume | — | 14,630,257 |
Dividend Yield | — | 2.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aurora Cannabis (ACB) trades at $2.99, up 0.34% with a bullish technical signal despite mixed earnings. The company achieved record annual medical cannabis revenue growth of 18% YoY to $288.6 million in FY2026, but faces margin pressure from Canadian reimbursement changes. Recent Q1 2027 earnings beat expectations with $0.04 EPS versus -$0.13 estimate, though revenue declined to $67.6 million. The stock shows strong institutional support with shareholder approval of board measures and EU-GMP certification for international expansion.
ACB presents a high-risk opportunity with significant volatility. While international medical cannabis growth and operational improvements provide upside potential, persistent net losses, negative ROE/ROA, and Canadian market challenges create substantial headwinds. Analyst consensus remains cautious with only 21% buy ratings, reflecting concerns about profitability timeline and competitive pressures in the evolving cannabis sector.
Coca-Cola (KO) trades at $86.48, down 0.65% on the day, with a bullish technical signal supported by moving averages and oversold RSI levels. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $0.97 exceeding the $0.92 estimate, and maintains robust profitability with a 28.56% net margin. Recent news highlights institutional buying and stable demand trends, while dividends continue with a $0.53 payout.
The outlook is positive with a consensus price target of $95.83 implying 11% upside, driven by earnings momentum and dividend reliability. Risks include regional demand volatility and high debt levels, but analyst sentiment is bullish with 60% buy ratings. The stock presents a steady growth opportunity with defensive income characteristics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aurora Cannabis Inc
Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.
Read more on ACB →About The Coca-Cola Co K
The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.
Read more on KO →
